We are live on ! Find out more
RNAM

Avidity Biosciences
RNAM

Delisted

RNAM was delisted on the 26th of February, 2026.

Back to rankings

1 hedge funds and large institutions have $236K invested in Avidity Biosciences in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 335 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.36% less ownership

Funds ownership: 99.37% → 0.01% (-99%)

100% less funds holding

Funds holding: 343 → 1 (-342)

100% less funds holding in top 10

Funds holding in top 10: 33 → 0 (-33)

100% less capital invested

Capital invested by funds: $10.8B → $236K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 335

Holders
1
Holders Change
-342
Holders Change %
-99.71%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
335
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$927M
2
RCM
RA Capital Management
Massachusetts
-$623M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$501M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$436M
5
PCM
Pentwater Capital Management
Florida
-$435M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
– -$78.8M -1,092,482 Closed
AllianceBernstein
27
AllianceBernstein
Tennessee
– -$75.5M -1,047,410 Closed
KC
28
Kryger Capital
United Kingdom
– -$75.4M -1,045,320 Closed
Northern Trust
29
Northern Trust
Illinois
– -$73.5M -1,019,087 Closed
CC
30
Casdin Capital
New York
– -$72.1M -1,000,000 Closed
FLSM
31
Frazier Life Sciences Management
California
– -$70.9M -983,125 Closed
WCMNY
32
Westchester Capital Management (New York)
New York
– -$69.4M -962,659 Closed
NAM
33
Nexpoint Asset Management
Texas
– -$66.6M -923,950 Closed
TCM
34
Tang Capital Management
California
– -$64.9M -900,000 Closed
Man Group
35
Man Group
United Kingdom
– -$64.8M -898,277 Closed
Squarepoint
36
Squarepoint
New York
– -$62.6M -868,200 Closed
AAM
37
Alpine Associates Management
Florida
– -$62.6M -867,530 Closed
SFM
38
Soros Fund Management
New York
– -$60.7M -840,976 Closed
JP Morgan Chase
39
JP Morgan Chase
New York
– -$59.2M -820,990 Closed
SI
40
Sofinnova Investments
California
– -$53.7M -745,116 Closed
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
– -$52.9M -733,010 Closed
Wellington Management Group
42
Wellington Management Group
Massachusetts
– -$52.2M -723,118 Closed
SC
43
Slotnik Capital
Texas
– -$51.6M -715,000 Closed
Bank of America
44
Bank of America
North Carolina
– -$51M -706,665 Closed
Verition Fund Management
45
Verition Fund Management
Connecticut
– -$49.1M -680,721 Closed
WP
46
Woodline Partners
California
– -$48.4M -671,623 Closed
Voloridge Investment Management
47
Voloridge Investment Management
Florida
– -$46.3M -642,224 Closed
Neuberger Berman Group
48
Neuberger Berman Group
New York
– -$44.9M -622,439 Closed
O
49
OrbiMed
New York
– -$44.7M -619,530 Closed
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
– -$44M -610,547 Closed
1
2
3 4 5

RNAM Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avidity Biosciences (RNAM) for Q1 2026, worth a combined $236K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 335 funds closed out of RNAM and 0 opened new positions — a net loss of 335 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $927M sold.

  • 1 institutional investor held Avidity Biosciences (RNAM) as of Q1 2026, down from 343 in Q4 2025.
  • Funds reported $236K of Avidity Biosciences stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avidity Biosciences positions in Q1 2026 and 335 closed out, a net change of -335 holders.
  • The largest Avidity Biosciences seller in Q1 2026 was BlackRock, an estimated $927M sold.

Based on aggregated 13F filings for Q1 2026.